跳至主要内容
临床试验/NCT07420803
NCT07420803招募中不适用

Efficacy Of Auricular Transcutaneous Vagus Nerve Stimulation In Treating Chronic Dizziness

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年3月23日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
60
试验地点
1
主要终点
Change in Dizziness Handicap Inventory (DHI) score

研究概览

简要总结

The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75, Persistent Postural-Perceptual Dizziness (PPPD) diagnosis per International Classification of Vestibular Disorders (ICVD).
  • Persistent dizziness ≥3 months and at least 1 dizziness exacerbation/day during 2-week run-in.
  • On stable medications/therapy for ≥4 weeks prior to baseline (if any).

排除标准

  • Uncompensated peripheral/central vestibular deficit, sensory-afferent or cerebellar ataxia.
  • Cardiac disease (coronary disease, unstable arrhythmia), recurrent syncope (>1 in past 12 months).
  • Neck surgery, vagotomy, or any condition interfering with vagal stimulation.
  • Pregnancy.

研究组 & 干预措施

Auricular transcutaneous vagus nerve stimulation

Experimental

The vagus nerve stimulation group will perform two sessions per day (morning and evening), each lasting approximately 30 minutes, for a total of 1 hour of auricular transcutaneous vagus nerve stimulation. This arm will continue using the active treatment for 8 weeks.

干预措施: Auricular transcutaneous vagus nerve stimulation (Other)

Sound sham electrodes

Sham Comparator

The sham control group will will perform two sessions per day (morning and evening), each lasting approximately 30 minutes, for a total of 1 hour of daily stimulation using the sham device. After 4 weeks, the sham control group will begin active auricular transcutaneous vagus nerve stimulation for 4 weeks.

干预措施: Sham Device (Other)

Sound sham electrodes

Sham Comparator

The sham control group will will perform two sessions per day (morning and evening), each lasting approximately 30 minutes, for a total of 1 hour of daily stimulation using the sham device. After 4 weeks, the sham control group will begin active auricular transcutaneous vagus nerve stimulation for 4 weeks.

干预措施: Auricular transcutaneous vagus nerve stimulation (Other)

结局指标

主要结局

Change in Dizziness Handicap Inventory (DHI) score

时间窗: Baseline, 4 weeks

The Dizziness Handicap Inventory (DHI) is a 25-item questionnaire assesses physical, emotional, and functional aspects of dizziness. Each of the 25 questions has three answers: "Always" (4 points), "Sometimes" (2 points), or "No" (0 points). Scores are summed for a total from 0 (no disability) to 100 (maximum disability).

次要结局

  • Change in Anxiety (HADS-A)(Baseline, 4 weeks and 8 weeks)
  • Change in Postural Sway(Baseline, 4 weeks and 8 weeks)
  • Weekly averages of dizzy-day frequency(Through end of study, approximately 8 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Colton T. Clayton

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

A Study Of Auricular Transcutaneous Vagus Nerve... | 临床试验